These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2315371)

  • 1. Failure of serotonin antagonist pizotifen to stimulate feeding or weight gain in free-feeding rats.
    Swiergiel AH; Peters G
    Pharmacol Biochem Behav; 1990 Jan; 35(1):61-7. PubMed ID: 2315371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural changes on diet selection and serotonin (5-HT) turnover in rats under pizotifen treatment.
    Galanopoulou P; Giannacopoulos G; Theophanopoulos C; Couvaris MK; Varonos D
    Pharmacol Biochem Behav; 1990 Nov; 37(3):461-4. PubMed ID: 1708144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus properties of pizotifen maleate (BC105): a putative serotonin antagonist.
    Minnema DJ; Hendry JS; Rosecrans JA
    Psychopharmacology (Berl); 1984; 83(2):200-4. PubMed ID: 6431474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the 5HT2 antagonist ritanserin on food intake and on 5HT-induced anorexia in the rat.
    Massi M; Marini S
    Pharmacol Biochem Behav; 1987 Feb; 26(2):333-40. PubMed ID: 3106990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxycitrate has long-term effects on feeding behavior, body weight regain and metabolism after body weight loss in male rats.
    Leonhardt M; Langhans W
    J Nutr; 2002 Jul; 132(7):1977-82. PubMed ID: 12097679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central action of pizotifen.
    Przegaliński E; Baran L; Palider W; Siwanowicz J
    Psychopharmacology (Berl); 1979 Apr; 62(3):295-300. PubMed ID: 111296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight gain with pizotifen therapy.
    Briars GL; Travis SE; Anand B; Kelly AM
    Arch Dis Child; 2008 Jul; 93(7):590-3. PubMed ID: 18381348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral 5-carboxamidotryptamine (5-CT) elicits drinking by stimulating 5-HT1-like serotonergic receptors in rats.
    Simansky KJ
    Pharmacol Biochem Behav; 1991 Feb; 38(2):459-62. PubMed ID: 1829233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N; Metys J; Valchár M; Soucek R
    Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of pizotifen, a serotonin antagonist, and of pirenzepine, a muscarinic antagonist, on hormonal responses to metoclopramide in healthy subjects.
    Jungmann E; Althoff PH; Hermann GJ; Schöffling K
    Arzneimittelforschung; 1984; 34(9):1022-4. PubMed ID: 6391497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral serotonin administration selectively reduces fat intake in rats.
    Kanarek RB; Dushkin H
    Pharmacol Biochem Behav; 1988 Sep; 31(1):113-22. PubMed ID: 3252241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation.
    Mylecharane EJ; Spira PJ; Misbach J; Duckworth JW; Lance JW
    Eur J Pharmacol; 1978 Mar; 48(1):1-9. PubMed ID: 416960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of insulin secretion from the perfused pancreas of the rat by pizotifen.
    Joost HG
    Br J Pharmacol; 1979 Oct; 67(2):265-7. PubMed ID: 387147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimigraine drug interactions with 5-hydroxytryptamine1A receptors.
    Hiner BC; Roth HL; Peroutka SJ
    Ann Neurol; 1986 May; 19(5):511-3. PubMed ID: 2940961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.
    Aellig WH
    Eur J Clin Pharmacol; 1983; 25(6):759-62. PubMed ID: 6662174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyproheptadine and pizotifen on central muscarinic receptors.
    Richards MH
    Eur J Pharmacol; 1991 Apr; 195(3):403-5. PubMed ID: 1868883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
    Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
    Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pizotifen increases 5-HIAA urinary excretion in male healthy volunteers.
    Elghozi JL; Laude D; Duprat P; Mignot E
    Eur J Clin Pharmacol; 1984; 27(2):191-6. PubMed ID: 6209146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel antagonism by pizotifen.
    Peroutka SJ; Banghart SB; Allen GS
    J Neurol Neurosurg Psychiatry; 1985 Apr; 48(4):381-3. PubMed ID: 2582093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary modulation of the anorectic potency of amphetamine.
    Marks-Kaufman R; Kanarek RB
    Pharmacol Biochem Behav; 1990 Feb; 35(2):301-6. PubMed ID: 2320637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.